139 related articles for article (PubMed ID: 7895492)
1. Regulation of terminal differentiation of human B-cells by IL-6.
Chen-Kiang S
Curr Top Microbiol Immunol; 1995; 194():189-98. PubMed ID: 7895492
[No Abstract] [Full Text] [Related]
2. Interleukin-6: a comprehensive review.
Lotz M
Cancer Treat Res; 1995; 80():209-33. PubMed ID: 8821579
[No Abstract] [Full Text] [Related]
3. Cytokine signal transduction through a homo- or heterodimer of gp130.
Kishimoto T; Tanaka T; Yoshida K; Akira S; Taga T
Ann N Y Acad Sci; 1995 Sep; 766():224-34. PubMed ID: 7486664
[No Abstract] [Full Text] [Related]
4. Interleukin-6: biologic properties and role in lymphoproliferative disorders.
Seymour JF; Kurzrock R
Cancer Treat Res; 1996; 84():167-206. PubMed ID: 8724631
[No Abstract] [Full Text] [Related]
5. Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors.
Udagawa N; Takahashi N; Katagiri T; Tamura T; Wada S; Findlay DM; Martin TJ; Hirota H; Taga T; Kishimoto T; Suda T
J Exp Med; 1995 Nov; 182(5):1461-8. PubMed ID: 7595216
[TBL] [Abstract][Full Text] [Related]
6. [IL-6 receptor and signal transduction pathway].
Nakajima K; Hirano T
Tanpakushitsu Kakusan Koso; 1991 Mar; 36(4):687-95. PubMed ID: 2063018
[No Abstract] [Full Text] [Related]
7. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
8. CD40 ligand triggers interleukin-6 mediated B cell differentiation.
Urashima M; Chauhan D; Hatziyanni M; Ogata A; Hollenbaugh D; Aruffo A; Anderson KC
Leuk Res; 1996 Jun; 20(6):507-15. PubMed ID: 8709623
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound and soluble interleukin-6 receptor: studies on structure, regulation of expression, and signal transduction.
Heinrich PC; Graeve L; Rose-John S; Schneider-Mergener J; Dittrich E; Erren A; Gerhartz C; Hemann U; Lütticken C; Wegenka U
Ann N Y Acad Sci; 1995 Jul; 762():222-36; discussion 236-7. PubMed ID: 7545364
[No Abstract] [Full Text] [Related]
10. Simultaneous activation of Ig and Oct-2 synthesis and reduction of surface MHC class II expression by IL-6.
Natkunam Y; Zhang X; Liu Z; Chen-Kiang S
J Immunol; 1994 Oct; 153(8):3476-84. PubMed ID: 7930570
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-5: an overview.
Takatsu K
Cancer Treat Res; 1995; 80():187-208. PubMed ID: 8821578
[No Abstract] [Full Text] [Related]
12. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: dimethyl sulfoxide inhibits IL-6-induced differentiation of SKW6-CL4 into IgM-secreting plasma cells.
Teraoka H; Mikoshiba M; Takase K; Yamamoto K; Tsukada K
Exp Cell Res; 1996 Jan; 222(1):218-24. PubMed ID: 8549666
[TBL] [Abstract][Full Text] [Related]
13. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
Hirano T; Matsuda T; Nakajima K
Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line.
Kumar G; Gupta S; Wang S; Nel AE
J Immunol; 1994 Nov; 153(10):4436-47. PubMed ID: 7963520
[TBL] [Abstract][Full Text] [Related]
15. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-13 (IL-13) pathway.
Kelly-Welch A; Hanson EM; Keegan AD
Sci STKE; 2005 Jul; 2005(293):cm8. PubMed ID: 16030286
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling.
Zhang P; Chebath J; Lonai P; Revel M
Stem Cells; 2004; 22(3):344-54. PubMed ID: 15153611
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor.
Shiiba M; Takaki S; Takatsu K
Int Arch Allergy Immunol; 1996; 111 Suppl 1():12-5. PubMed ID: 8906104
[TBL] [Abstract][Full Text] [Related]
19. CD38 ligation induces tyrosine phosphorylation of Bruton tyrosine kinase and enhanced expression of interleukin 5-receptor alpha chain: synergistic effects with interleukin 5.
Kikuchi Y; Yasue T; Miyake K; Kimoto M; Takatsu K
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11814-8. PubMed ID: 8524855
[TBL] [Abstract][Full Text] [Related]
20. [Structure and function of IL-5 receptor].
Takatsu K
Yakugaku Zasshi; 1995 Aug; 115(8):570-83. PubMed ID: 7473055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
